May 22, 2020
Date: Aug 10, 2023
FDA has a new Commissioner, industry is debating if the 25-year-old dietary supplement laws should be updated, and consumer class action lawsuits continually filed. What does the future hold for the regulation of probiotics (and prebiotics and postbiotics) in foods, dietary supplements and cosmetics? Anticipating legal roadblocks is key to success for brands that are considering launching a new product or have a product already on the market. Ivan Wasserman will provide the latest information and answer your questions.
Ivan Wasserman, managing partner, Amin Talati Wasserman LLP
Ivan Wasserman is the Managing Partner of leading regulatory and intellectual property law firm Amin Talati Wasserman LLP. Noted for expertise in foods, dietary supplements and cosmetics, Ivan and his team represent clients before the FDA, the FTC, State Attorneys General, and in class action litigation. Ivan also serves as counsel to the International Probiotics Association, is a frequent speaker and author on regulatory issues, and has been included in Best Lawyers in America from 2007 to 2020.
You May Also Like
Sep 28, 2023
Innovation in stress and sleep management: Holixer™– white paperSep 22, 2023
Cognitive health growth comes out on top: A range of solutions for diverse needs continue to emerge and win – product development guideSep 25, 2023
LifeVantage proxy fight heats up as revenues coolSep 28, 2023
The ashwagandha root production process: Where tradition meets science – article part threeSep 21, 2023